171 Ashley Ave.
Charleston, SC 29425
843-792-1414
800-424-MUSC
|
 |
DCRI celebrates its first year of existence
byHeather Woolwine
MUSC Public Relations
February 24, 2006
On Feb. 16, scientists, administrators, and those interested in the
Darby Children’s Research Institute’s (DCRI) progress were treated to a
multi-floor exhibition highlighting a year’s worth of work.
Since its opening last February, the DCRI’s throng of researchers and
scientists completed an impressive amount of study related to the
health and well-being of children.
The two-day celebration sought to remind those at MUSC that the DCRI
was created to strengthen children’s research at MUSC and thus improve
the lives of children and their families. By conducting high quality
research, training physicians and scientists, and by fostering
innovation through discovery and application, the DCRI family serves to
bring innovative and groundbreaking research into the health care
system of the 21st century.
The poster session on Feb. 16 on the second through sixth floors
demonstrated the vast amount of research that has been completed and
intensified during the last year, as well as providing an opportunity
for the hard-working scientists, researchers, and clinicians to show
their work.
“The National Institutes of Health is seeking a reorganization of
clinical and translational research to accelerate the application of
new basic science discoveries into clinical application,” said Bernie
Maria, M.D., DCRI executive director. “The DCRI is ideally organized to
enhance translational research that improves lives of children served
in the Children’s Hospital. Dr. Scott Pomeroy joined us from
Harvard University is a fine example of contributions made in
children’s translational research.”
Pomeroy, M.D., Ph.D., Neuro-oncology director at the Children’s
Hospital of Boston at Harvard Medical School and Neurology chairman,
gave two lectures Feb. 16 entitled, “Using gene expression profiles to
identify subtypes of CNS embryonal tumors” and “Genomics in Clinical
Medicine.” His talk on Feb. 17 for pediatric grand rounds was entitled,
“Developing molecular markers for risk stratification of
medulloblastomas.”
Pomeroy holds two patents, received numerous honors and awards, and has
penned or collaborated on more than 100 publications, reviews, and
books. A sought-after speaker, he has appeared throughout the country
in addition to many administrative and clinical appointments throughout
his career. He maintains membership in several professional societies
and participates in numerous community service activities and on
several editorial boards.
|
|
Print Version